Back to User profile » Drs David Kopsky
Papers published by Drs David Kopsky:
Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review
Kopsky DJ, Szadek KM, Schober P, Vrancken AFJE, Steegers MAH
Journal of Pain Research 2022, 15:479-496
Published Date: 17 February 2022
No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action
Kopsky DJ, Keppel Hesselink JM, Russell AL, Vrancken AFJE
Journal of Pain Research 2022, 15:377-383
Published Date: 9 February 2022
Usefulness of a Double-Blind Placebo-Controlled Response Test to Demonstrate Rapid Onset Analgesia with Phenytoin 10% Cream in Polyneuropathy
Kopsky DJ, Vrancken AFJE, Keppel Hesselink JM, van Eijk RPA, Notermans NC
Journal of Pain Research 2020, 13:877-882
Published Date: 1 May 2020
Topical loperamide for the treatment of localized neuropathic pain: a case report and literature review
Kopsky DJ, Bhaskar AK, Zonneveldt HJ, Keppel Hesselink JM
Journal of Pain Research 2019, 12:1189-1192
Published Date: 29 April 2019
Ethical justification of single-blind and double-blind placebo-controlled response tests in neuropathic pain and N-of-1 treatment paradigm in clinical settings
Keppel Hesselink JM, Kopsky DJ, Bhaskar AK
Journal of Pain Research 2019, 12:345-352
Published Date: 14 January 2019
Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design
Keppel Hesselink JM, Kopsky DJ, Stahl SM
Journal of Pain Research 2017, 10:635-641
Published Date: 20 March 2017
Topical phenytoin for the treatment of neuropathic pain
Kopsky DJ, Keppel Hesselink JM
Journal of Pain Research 2017, 10:469-473
Published Date: 27 February 2017
Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics
Keppel Hesselink JM, Kopsky DJ, Bhaskar AK
Journal of Pain Research 2017, 10:1-8
Published Date: 16 December 2016
New topical treatment of vulvodynia based on the pathogenetic role of cross talk between nociceptors, immunocompetent cells, and epithelial cells
Keppel Hesselink JM, Kopsky DJ, Sajben N
Journal of Pain Research 2016, 9:757-762
Published Date: 3 October 2016
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
Keppel Hesselink JM, Kopsky DJ
Journal of Pain Research 2015, 8:729-734
Published Date: 23 October 2015
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
Keppel Hesselink JM, Kopsky DJ
Journal of Pain Research 2013, 6:239-245
Published Date: 21 March 2013